Distribution of the tight junction proteins ZO-1, occludin, and claudin-4, -8, and -12 in bladder epithelium
With regard to the effects of cerebellar stimulation on spasticity and other movement disorders, it is interesting that the effects are often delayed [131], just as they are in dystonic patients who are treated with pallidal interventions, suggesting that the stimulation may not only act to acutely alter synaptic transmission in brain areas downstream from the stimulation, but may lead to prominent subacute or chronic plastic changes in thalamus or cortex
The bottom line is that we needed replication of these ndings with additional studies to answer these and other questions
The scheduled PCAC review on July 23, 2026, will be a defining moment not just for BPC-157, but for the broader peptide therapy industry
Nature Communications , 13 (1), 6128
Key Takeaways Topical peptides (especially GHK-Cu): Well-supported by human clinical studies for skincare